At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 419 enrolled
Drug / intervention
Encore Mobile-Bearing Kneedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Encore Mobile - Bearing Knee Study #200
In Brief
A Phase 3 clinical trial evaluating Encore Mobile-Bearing Knee for Inflammatory Tissue Disorder and 4 related conditions. Completed, enrolled 419 participants across 8 sites.
Detailed Summary
To evaluate the safety and efficacy of the Encore Mobile-Bearing Knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Tissue Disorder, Osteoarthritis, Avascular Necrosis, Post-traumatic Arthritis, Secondary Arthritis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2000
Primary CompletionJun 2008
Study CompletionAug 2008
First PostedOct 2008
TodayJul 2026
First PostedOct 2, 2008
Enrollment StartJan 1, 2000
Primary CompletionJun 1, 2008
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 8.4 yearsPosted 17.8 years ago
Interventions
Encore Mobile-Bearing Kneedevice
Used for primary total knee replacement